CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets

Rosilene Motta Elias1,2, Maria Aparecida Dalboni1, Ana Carolina E Coelho3

  • 1Universidade Nove de Julho, UNINOVE, Rua Iperoig, 690 ap 121, São Paulo, SP, 05016-000, Brazil.

Insights

Chronic kidney disease-mineral and bone disorder (CKD-MBD) pathophysiology is better understood, but treatments remain limited. New research highlights osteocyte dysfunction as a key factor, suggesting novel therapeutic targets for CKD-MBD.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Biology

Background:

  • Chronic kidney disease-mineral and bone disorder (CKD-MBD) remains a significant clinical challenge with high mortality.
  • Despite advances in understanding CKD-MBD pathophysiology, therapeutic options have not significantly improved patient outcomes or quality of life.

Purpose of the Study:

  • To review traditional and updated pathophysiology of CKD-MBD.
  • To discuss current therapeutic limitations and explore novel treatment targets for CKD-MBD.

Main Methods:

  • Literature review of recent advancements in CKD-MBD research.
  • Analysis of the role of osteocytes in CKD-MBD.
  • Discussion of emerging therapeutic strategies.

Main Results:

  • The osteocyte is now recognized as a central player in CKD-MBD, shifting from the traditional view of bone as a target organ.
  • Osteocytes, through factors like FGF-23 and sclerostin, act as endocrine regulators, suggesting dysregulation may be an early CKD event.
  • Current treatments for CKD-MBD face limitations, necessitating exploration of alternative approaches.

Conclusions:

  • A paradigm shift in understanding CKD-MBD positions osteocytes as key regulators, offering new avenues for therapeutic intervention.
  • Targeting osteocyte function presents a promising strategy to improve management and outcomes for CKD-MBD patients.
  • Further research into osteocyte-centric therapies is crucial for addressing the unmet needs in CKD-MBD treatment.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
645
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
874
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Potential Energy00:52

Potential Energy

The energy stored by a structure and location of matter in space is called potential energy. For instance, raising a kettlebell changes its spatial location and increases its potential energy. Similarly, a stretched rubber band contains potential energy which, under certain conditions, can be converted into other forms of energy, such as kinetic energy.
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
42.7K